KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Preferred Shares: 2015-2017

Historic Preferred Shares for Teva Pharmaceutical Industries (TEVA) over the last 3 years, with Dec 2017 value amounting to $3.6 billion.

  • Teva Pharmaceutical Industries' Preferred Shares was N/A to $3.8 billion in Q3 2018 from the same period last year, while for Sep 2018 it was $3.8 billion, marking a year-over-year change of. This contributed to the annual value of $3.6 billion for FY2017, which is 0.30% up from last year.
  • According to the latest figures from FY2017, Teva Pharmaceutical Industries' Preferred Shares is $3.6 billion, which was up 0.30% from $3.6 billion recorded in FY2016.
  • Over the past 5 years, Teva Pharmaceutical Industries' Preferred Shares peaked at $3.6 billion during FY2017, and registered a low of $3.3 billion during FY2015.
  • Its 3-year average for Preferred Shares is $3.5 billion, with a median of $3.6 billion in 2016.
  • Data for Teva Pharmaceutical Industries' Preferred Shares shows a peak YoY climbed of 10.00% (in 2016) over the last 5 years.
  • Yearly analysis of 3 years shows Teva Pharmaceutical Industries' Preferred Shares stood at $3.3 billion in 2015, then rose by 10.00% to $3.6 billion in 2016, then rose by 0.30% to $3.6 billion in 2017.